Jefferson Daniel
Overview
Explore the profile of Jefferson Daniel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christopher D, Gupta R, Thangakunam B, Daniel J, Jindal S, Kant S, et al.
Lung India
. 2024 May;
41(3):230-248.
PMID: 38704658
Pleural effusion is a common problem in our country, and most of these patients need invasive tests as they can't be evaluated by blood tests alone. The simplest of them...
2.
Williams I, Daniel J, Mansur A, Christopher D, Krishna M
Clin Exp Allergy
. 2024 Mar;
54(6):444-447.
PMID: 38499494
No abstract available.
3.
Inbaraj L, Shewade H, Daniel J, Srinivasalu V, Paul J, Satish S, et al.
Front Med (Lausanne)
. 2023 Jul;
10:1085010.
PMID: 37415768
Background: We aimed to determine the effectiveness and safety of the Levofloxacin-containing regimen that the World Health Organization is currently recommending for the treatment of Isoniazid mono-resistant pulmonary Tuberculosis. Methods:...
4.
Daniel J, Christopher D
Clin Exp Allergy
. 2023 Jul;
53(7):693-696.
PMID: 37401046
No abstract available.
5.
Christopher D, Natania A, Daniel J, Balamugesh T, Isaac B, Krishna M
Clin Exp Allergy
. 2023 Jun;
53(7):781-784.
PMID: 37365847
No abstract available.
6.
Daniel J, Gupta R, Thangakunam B, Christopher D
Heliyon
. 2023 Apr;
9(4):e14711.
PMID: 37025820
Patients who have features of both Asthma & COPD are now known as Asthma COPD overlap (ACO). Prevalence of ACO based on the Global Initiative for Asthma (GINA) and Global...
7.
Wagner C, Griesel M, Mikolajewska A, Metzendorf M, Fischer A, Stegemann M, et al.
Cochrane Database Syst Rev
. 2022 Nov;
11:CD014963.
PMID: 36385229
Background: Systemic corticosteroids are used to treat people with COVID-19 because they counter hyper-inflammation. Existing evidence syntheses suggest a slight benefit on mortality. Nonetheless, size of effect, optimal therapy regimen,...
8.
Isaac B, Priya N, Nair A, Thangakunam B, Balachandran A, George T, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2022 Apr;
6(3):239-249.
PMID: 35463482
Objective: To study the outcomes of noninvasive ventilation (NIV) administered through a tabletop device for coronavirus disease 2019 acute respiratory distress syndrome in the respiratory intermediate care unit (RIMCU) at...
9.
Griesel M, Wagner C, Mikolajewska A, Stegemann M, Fichtner F, Metzendorf M, et al.
Cochrane Database Syst Rev
. 2022 Mar;
3:CD015125.
PMID: 35262185
Background: Inhaled corticosteroids are well established for the long-term treatment of inflammatory respiratory diseases such as asthma or chronic obstructive pulmonary disease. They have been investigated for the treatment of...
10.
Daniel J, Thangakunam B, Isaac B, Moorthy M, Christopher D
Respirol Case Rep
. 2021 Dec;
10(1):e0891.
PMID: 34934508
Patients with immunodeficiency are at an increased risk of recurrent COVID-19 infection. They may lack the natural immune response that usually confers long-lasting immunity. Here, we present our experience managing...